Abstract
Background: Advances in coronary stent design have reduced rates of coronary restenosis and the need for further revascularisation. However, compared with second-generation (2nd-Gen) drug-eluting stents (DES), first-generation(1st-Gen) DES and bioresorbable coronary scaffolds (BVS) have an increased risk of stent thrombosis (ST), which may not have been adequately assessed in individual studies. A meta-analysis was undertaken to evaluate the best choice of endpoint and follow-up duration, to detect any increased risk of stent or scaffold thrombosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
